TerminatedNot Applicable

Prediction of Chronic Pain by the Pain Monitor

Stopped: Difficulties of recrutment

France6 participantsStarted 2012-03-07

Plain-language summary

The skin conductance algesimeter (Pain Monitor™, Med-Storm Innovation AS, NO-0264 Oslo, Norway)) reflects the sympathetic nervous system by the measurement of the skin conductance of the palm of the hand. SCA detects nociceptive pain fast and continuously, specific to the individual, with higher sensitivity and specificity than other available objective methods. The skin conductance response to a calibrated noxious stimulus varies among patients. It defines two types of people depending on its magnitude. The investigators assume that the importance of skin conductance response to a noxious stimulus predicts the occurrence of chronic pain in patients operated by thoracotomy.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients of both sexes * planned pulmonary resection for cancer performed by a posterolateral thoracotomy * thoracic epidural analgesia Exclusion Criteria: * pregnancy, * morbid obesity, * insulin-dependent diabetes with dysautonomia, * inability to proceed with anesthesia using the BIS signal, * known allergy to remifentanil, propofol, atracurium or to levobupivacaine, * contra-indication to nefopam * contra-indication to ketoprofen

What they're measuring

Prediction of chronic pain

Timeframe: one year after surgery

Trial details

NCT IDNCT01595711

SponsorHopital Foch

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-09-07

View on ClinicalTrials.gov More Surgery trials